Developer docs
API playgroundTry for free, no card

Search company profiles

MemTrax

Full company profile

uuid002olhr

Namestring
MemTrax
Legal namestring
MemTrax llc
Websiteurl
memtrax.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

MemTrax is a Redwood City, California-based health technology company (MemTrax LLC) that operates an online cognitive assessment platform centered on a proprietary picture-based continuous recognition memory test. The test, which takes approximately three minutes to complete, measures learning and short-term memory performance and produces a Brain Health Score intended for early detection and longitudinal tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. The underlying methodology was developed by founder Dr. J. Wesson Ashford starting in 1985, has Stanford IRB-approved research validation, and is supplemented by machine learning-based classification of MCI published in the Journal of Alzheimer's Disease (2020). A secondary Finger Tapping Test module extends the suite into motor-cognitive assessment.

MemTrax serves primarily individual consumers concerned about memory loss and cognitive aging through a freemium, direct-to-consumer model on memtrax.com, with secondary reach into healthcare providers and researchers via institutional endorsements (Stanford, Yale Medicine, Alzheimer's Foundation of America) and into corporate wellness programs. The platform is available globally in 120+ languages, 24/7, and emphasizes anonymity, no-credit-card trials, and visualized longitudinal results. Distribution is anchored on the company's own website and on the Alzheimer's Foundation of America's website as their featured memory test, providing institutional credibility without an enterprise sales motion.

The company is privately held, appears to be bootstrapped with no disclosed external funding, and operates with 1-10 employees. Its brand is trademarked (MemTrax™), its marketing is content-driven (brain health blog, SEO, social media), and its revenue mechanics are subscription-based premium plans layered over a free basic test. No mobile app, public API, certifications, regulatory clearances (e.g., FDA), or institutional investors are disclosed.

Short descriptiontext

MemTrax is a privately held health technology company offering a proprietary picture-based online memory test for early detection and tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. It serves individual consumers via a freemium subscription model and is distributed through endorsements from Stanford, Yale Medicine, and the Alzheimer's Foundation of America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRedwood City, United States
HQ citystring
Redwood City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
online memory test, cognitive assessment software, brain health screening, dementia early detection, memory tracking platform
Industry2 codes
PRIMARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Testing Laboratories8734
Product category
Digital Cognitive Health Assessment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription Plans
TypeSubscription Recurring
Description

MemTrax offers tiered subscription plans for ongoing memory testing and tracking. The website mentions 'Plans' and 'Pricing' pages, indicating a subscription-based model with risk-free trials and no credit card required for initial signup.

memtrax.com
2Freemium Test Access
TypeFreemium
Description

Basic memory test available for free with premium features (unlimited tests, detailed tracking, history) available through paid subscription.

memtrax.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Free Basic Test
ModelFreemiumBilling cadencePay-as-you-go
Notes

Basic memory test available at no cost with limited tracking and test history.

memtrax.com
2Premium Subscription Plans
ModelSubscriptionBilling cadenceMonthly
Notes

Paid subscription offering unlimited memory tests, full test history, detailed analytics, and enhanced brain health tracking. Risk-free trial period available.

memtrax.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

MemTrax provides a web-based, picture-based continuous recognition memory test that screens learning and short-term memory performance in approximately 3 minutes, returning a Brain Health Score to help users track cognitive change over time. The platform is offered on a freemium basis, with paid subscription plans unlocking unlimited tests, full history, and detailed analytics, and is paired with a Finger Tapping Test for motor assessment. Target use cases include early detection of Mild Cognitive Impairment, dementia, and Alzheimer's disease for self-monitoring individuals and supporting research and clinical screening.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Test completion in approximately 3 minutes
+2 more records
Product overview1 text field

MemTrax is a health technology company offering a suite of cognitive assessment tools centered around its core Online Memory Test. The primary offering is the MemTrax Memory Test, a picture-based cognitive screening tool that measures short-term memory function and provides a Brain Health Score to detect early signs of memory impairment, MCI, dementia, and Alzheimer's disease. The product suite includes a Finger Tapping Test (Tap Test) as an additional assessment module. The MemTrax test was developed by Dr. Wes Ashford and has been validated through Stanford IRB research and used in partnership with organizations like the Alzheimer's Foundation of America. The test is available online 24/7, supports over 120 language translations, and takes approximately 3 minutes to complete.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

The Alzheimer's Foundation of America features MemTrax as their official memory test resource on their website, recognizing its precision and power for cognitive screening. This partnership provides significant credibility and distribution through a major nonprofit organization focused on dementia care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Stanford IRB-approved research study validating the MemTrax memory test methodology. The test was developed by Dr. J. Wesson Ashford, a Stanford-trained psychiatrist with decades of research in cognitive assessment.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Amos Adare, Neurosurgeon at Yale Medicine, endorses MemTrax, providing credibility within the medical research community.

4Journal of Alzheimer's Disease
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Published peer-reviewed research including 'Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment' (2020) validating the technology.

memtrax.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Altoida uses AI and augmented reality on smartphones to assess cognitive function and predict Alzheimer's risk. It overlaps with MemTrax on AI-driven cognitive assessment but differentiates through AR-based digital biomarkers and FDA Breakthrough Device designation.

TypeDirect peer
Description

Cambridge Cognition offers digital cognitive assessment solutions for clinical trials, research, and healthcare providers, including tests for memory, attention, and executive function. It is one of the closest direct competitors to MemTrax in computerized memory testing with validated clinical positioning.

TypeDirect peer
Description

Creyos provides online cognitive assessments measuring memory, reasoning, and attention for both consumer health and clinical/research use. It competes directly with MemTrax in the digital cognitive assessment market with a broader product suite and stronger commercial traction.

TypeDirect peer
Description

Cogstate provides computerized cognitive assessment tools used in clinical trials, research, and healthcare — directly comparable to MemTrax in offering brief, validated cognitive tests with a similar end-market focus on memory and cognition, but at much greater scale and with FDA-cleared products.

TypeDirect peer
Description

CNS Vital Signs provides computerized neurocognitive testing platforms for clinicians and researchers, including memory domain assessments. It is a direct comparable in computerized cognitive testing with established healthcare-provider distribution.

TypeDirect peer
Description

BrainCheck offers a digital cognitive assessment platform used by clinicians to detect and manage cognitive impairment, concussion, and dementia. It is a direct competitor in the cognitive screening space with a focus on healthcare-provider customers, similar to MemTrax's secondary healthcare segment.

TypeBroad incumbent
Description

Lumosity operates a large-scale consumer brain-training platform with cognitive assessments across multiple domains including memory. While its primary positioning is brain training rather than clinical screening, it competes with MemTrax for consumer attention in the cognitive health space.

TypeDirect peer
Description

Cognivue is an FDA-cleared digital cognitive screening device used in primary care to detect early signs of cognitive impairment. It competes with MemTrax in the cognitive assessment category but with a regulated medical-device positioning and clinical workflow focus.

TypeEmerging player
Description

Savonix offers a mobile cognitive assessment platform providing digital neurocognitive testing across domains including memory. It is a niche competitor in digital cognitive testing with partial overlap with MemTrax's short-term memory assessment focus.

TypeEmerging player
Description

Neurotrack develops digital cognitive health tools focused on memory assessment and dementia risk screening, including a 5-minute online test. It overlaps with MemTrax on the consumer-facing memory test concept, with partial overlap on AI-based screening.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MemTrax

Digital Cognitive Health Assessmentmemtrax.com

MemTrax is a privately held health technology company offering a proprietary picture-based online memory test for early detection and tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. It serves individual consumers via a freemium subscription model and is distributed through endorsements from Stanford, Yale Medicine, and the Alzheimer's Foundation of America.

What MemTrax does

MemTrax is a Redwood City, California-based health technology company (MemTrax LLC) that operates an online cognitive assessment platform centered on a proprietary picture-based continuous recognition memory test. The test, which takes approximately three minutes to complete, measures learning and short-term memory performance and produces a Brain Health Score intended for early detection and longitudinal tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. The underlying methodology was developed by founder Dr. J. Wesson Ashford starting in 1985, has Stanford IRB-approved research validation, and is supplemented by machine learning-based classification of MCI published in the Journal of Alzheimer's Disease (2020). A secondary Finger Tapping Test module extends the suite into motor-cognitive assessment.

MemTrax serves primarily individual consumers concerned about memory loss and cognitive aging through a freemium, direct-to-consumer model on memtrax.com, with secondary reach into healthcare providers and researchers via institutional endorsements (Stanford, Yale Medicine, Alzheimer's Foundation of America) and into corporate wellness programs. The platform is available globally in 120+ languages, 24/7, and emphasizes anonymity, no-credit-card trials, and visualized longitudinal results. Distribution is anchored on the company's own website and on the Alzheimer's Foundation of America's website as their featured memory test, providing institutional credibility without an enterprise sales motion.

The company is privately held, appears to be bootstrapped with no disclosed external funding, and operates with 1-10 employees. Its brand is trademarked (MemTrax™), its marketing is content-driven (brain health blog, SEO, social media), and its revenue mechanics are subscription-based premium plans layered over a free basic test. No mobile app, public API, certifications, regulatory clearances (e.g., FDA), or institutional investors are disclosed.

MemTrax firmographics

Firmographics
Name
MemTrax
Legal name
MemTrax llc
Website
https://memtrax.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
MemTrax is a privately held health technology company offering a proprietary picture-based online memory test for early detection and tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. It serves individual consumers via a freemium subscription model and is distributed through endorsements from Stanford, Yale Medicine, and the Alzheimer's Foundation of America.
Ownership category
akta.pro rank

MemTrax industry classification

Industry
Product category
Digital Cognitive Health Assessment
NAICS
Medical Laboratories (621511)
SIC
Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Online memory test
  • Cognitive assessment software
  • Brain health screening
  • Dementia early detection
  • Memory tracking platform

Where MemTrax is headquartered

Location

Headquarters

HQ city
Redwood City
HQ country
United States
HQ region
North America

Markets served

MemTrax business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription Plans: MemTrax offers tiered subscription plans for ongoing memory testing and tracking. The website mentions 'Plans' and 'Pricing' pages, indicating a subscription-based model with risk-free trials and no credit card required for initial signup.
  2. Freemium Test Access: Basic memory test available for free with premium features (unlimited tests, detailed tracking, history) available through paid subscription.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Basic Test
SubscriptionMonthlyPremium Subscription Plans

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

MemTrax product offering

Product offering

Core offering

MemTrax provides a web-based, picture-based continuous recognition memory test that screens learning and short-term memory performance in approximately 3 minutes, returning a Brain Health Score to help users track cognitive change over time. The platform is offered on a freemium basis, with paid subscription plans unlocking unlimited tests, full history, and detailed analytics, and is paired with a Finger Tapping Test for motor assessment. Target use cases include early detection of Mild Cognitive Impairment, dementia, and Alzheimer's disease for self-monitoring individuals and supporting research and clinical screening.

Product overview

MemTrax is a health technology company offering a suite of cognitive assessment tools centered around its core Online Memory Test. The primary offering is the MemTrax Memory Test, a picture-based cognitive screening tool that measures short-term memory function and provides a Brain Health Score to detect early signs of memory impairment, MCI, dementia, and Alzheimer's disease. The product suite includes a Finger Tapping Test (Tap Test) as an additional assessment module. The MemTrax test was developed by Dr. Wes Ashford and has been validated through Stanford IRB research and used in partnership with organizations like the Alzheimer's Foundation of America. The test is available online 24/7, supports over 120 language translations, and takes approximately 3 minutes to complete.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Test completion in approximately 3 minutes
  • +2 more outcomes

Companies that use MemTrax

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

MemTrax technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

MemTrax partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Alzheimer's Foundation of AmericacoreGTM or Marketing PartnerThe Alzheimer's Foundation of America features MemTrax as their official memory test resource on their website, recognizing its precision and power for cognitive screening. This partnership provides significant credibility and distribution through a major nonprofit organization focused on dementia care.
  • Stanford University ResearchcoreStrategic or Co-development PartnerStanford IRB-approved research study validating the MemTrax memory test methodology. The test was developed by Dr. J. Wesson Ashford, a Stanford-trained psychiatrist with decades of research in cognitive assessment.
  • Yale MedicineminorStrategic or Co-development PartnerDr. Amos Adare, Neurosurgeon at Yale Medicine, endorses MemTrax, providing credibility within the medical research community.
  • Journal of Alzheimer's DiseasecoreStrategic or Co-development PartnerPublished peer-reviewed research including 'Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment' (2020) validating the technology.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

MemTrax competitors and assessment

Company assessment

Emerging players

  • Altoida: Altoida uses AI and augmented reality on smartphones to assess cognitive function and predict Alzheimer's risk. It overlaps with MemTrax on AI-driven cognitive assessment but differentiates through AR-based digital biomarkers and FDA Breakthrough Device designation.
  • Savonix: Savonix offers a mobile cognitive assessment platform providing digital neurocognitive testing across domains including memory. It is a niche competitor in digital cognitive testing with partial overlap with MemTrax's short-term memory assessment focus.
  • Neurotrack: Neurotrack develops digital cognitive health tools focused on memory assessment and dementia risk screening, including a 5-minute online test. It overlaps with MemTrax on the consumer-facing memory test concept, with partial overlap on AI-based screening.

Direct peers

  • Cambridge Cognition: Cambridge Cognition offers digital cognitive assessment solutions for clinical trials, research, and healthcare providers, including tests for memory, attention, and executive function. It is one of the closest direct competitors to MemTrax in computerized memory testing with validated clinical positioning.
  • Creyos (formerly Cambridge Brain Sciences): Creyos provides online cognitive assessments measuring memory, reasoning, and attention for both consumer health and clinical/research use. It competes directly with MemTrax in the digital cognitive assessment market with a broader product suite and stronger commercial traction.
  • Cogstate: Cogstate provides computerized cognitive assessment tools used in clinical trials, research, and healthcare — directly comparable to MemTrax in offering brief, validated cognitive tests with a similar end-market focus on memory and cognition, but at much greater scale and with FDA-cleared products.
  • CNS Vital Signs: CNS Vital Signs provides computerized neurocognitive testing platforms for clinicians and researchers, including memory domain assessments. It is a direct comparable in computerized cognitive testing with established healthcare-provider distribution.
  • BrainCheck: BrainCheck offers a digital cognitive assessment platform used by clinicians to detect and manage cognitive impairment, concussion, and dementia. It is a direct competitor in the cognitive screening space with a focus on healthcare-provider customers, similar to MemTrax's secondary healthcare segment.
  • Cognivue: Cognivue is an FDA-cleared digital cognitive screening device used in primary care to detect early signs of cognitive impairment. It competes with MemTrax in the cognitive assessment category but with a regulated medical-device positioning and clinical workflow focus.

Broad incumbents

  • Lumos Labs (Lumosity): Lumosity operates a large-scale consumer brain-training platform with cognitive assessments across multiple domains including memory. While its primary positioning is brain training rather than clinical screening, it competes with MemTrax for consumer attention in the cognitive health space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

MemTrax social profiles

Digital presence

MemTrax financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MemTrax leadership team

Management profile

Number of profiles

Profiles1 record

MemTrax funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MemTrax M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MemTrax

What does MemTrax do?

MemTrax provides a web-based, picture-based continuous recognition memory test that screens learning and short-term memory performance in approximately 3 minutes, returning a Brain Health Score to help users track cognitive change over time. The platform is offered on a freemium basis, with paid subscription plans unlocking unlimited tests, full history, and detailed analytics, and is paired with a Finger Tapping Test for motor assessment. Target use cases include early detection of Mild Cognitive Impairment, dementia, and Alzheimer's disease for self-monitoring individuals and supporting research and clinical screening.

Is MemTrax a public or private company?

MemTrax is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MemTrax founded?

MemTrax was founded in 2015. It employs 1 to 10 people.

Where is MemTrax based?

MemTrax is headquartered in Redwood City, United States, in the North America region.

How does MemTrax make money?

Two revenue lines are on record. Subscription Plans are the primary driver. The others are freemium Test Access.

Who are MemTrax's main competitors?

Emerging players on record are Altoida, Savonix and Neurotrack. Direct peers are Cambridge Cognition, Creyos (formerly Cambridge Brain Sciences), Cogstate, CNS Vital Signs, BrainCheck and Cognivue. Lumos Labs (Lumosity) is listed as a broad incumbent.

Does MemTrax have an API?

No public API is recorded for MemTrax.

What industry is MemTrax in?

MemTrax's product category is Digital Cognitive Health Assessment. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 621511 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals